Don't worry Slants will change his mind real soon!

Here it goes, AMBS in December will be higher!

Makes me think we have multiple suiters after us?

Perfect post! Well done.

Bond, James Bond.... Nice call!

Yes, that's what people told me when I bought Amgen back in 1987. You'll find your niche!

I'm up 160k in $AMBS so far and holding for 5 to 10. Years. huge pipeline with more potential then I have seen in a start up biotech in a very long time..... IMHO

What?

Listen miss informed, we're not $MINE with 2.44 billion or $MYEC with 2.37 billion shares. Yes billions! $AMBS has 732 million which is more like say $AMGN which has 759 million.....

Wake up and stop following Sol.

Risk is Dave Ludlow!

True dat!

Imagine the media buzz at the U. N. on Thursday Dave..... I think (opinion only) that the partner is announced before the revenue guidance is given.... Or.... at the same time?

Wednesday at the close of the markets! IMHO

DR. Louis Kirby commenting is a nice addition!

Marked.

All signals are screaming GO

It's a blood test, the holy grail of diagnostics! Easy for the lab...

This thing is ready for take off!!

Interesting! I wonder just how much information Jason has gathered from the Commish? I would venture to say not all that much! IMHO

True story!

I can see that.... I'm looking at guidance around 10ml a month to start and with 731ml SO that would make the PPS some where between .984 and 2.132. With a 6x to 13x valuation. We still need up front cash and/or grants to get our PPS high enough to uplist..... They must have someone wanting to partner with Elto or RP as well, who knows what is going on behind closed doors?

Risk, it was a general statement... If you think 50ml is more accurate then split those numbers in half. I was basing those figures per every 100ml in revenue. I think 6 to 13x valuation is conservative.

I see you wrote it but I don't see it in your PPS estimate, I'm not trying to be argumentative just trying to get your thought? For every 100 ml in revenue with 730ml shares the PPS would be .137 x20 valuation would be 2.74, I see it more conservative at 6 to 13x...... For a PPS of .82 to 1.78.... We need revenue guidance to give us a starting point. I am real excited with both our scenarios!! $AMBS

Don't forget to add in valuation.... 6x, 12x, 18x or 23x?????

You mean .13.....


Quote
Email Alerts
IR Contacts
RSS News Feed
Detailed Quote for AMARANTUS BIOSCIENCE HLDG (AMBS)
$ 0.124 -0.002 (-1.59%) Volume: 10.04m 3:56 PM EDT Jul 17, 2014
After Hours: $ 0.13 0.006 (+4.84%) Volume: 16k 4:00 PM EDT Jul 17, 2014

Acceptable for all big pharma's to buy to test their subjects! Get a clue.

That's a popular tee time for Hacker's!!!

I agree....

@fibonacci1170: @MainePerks #Lympro have to prove safety+clinical perform. in 0.5-1K subjects. Can take 18-24 months. $0.5B license deal 2014 on cards $AMBS

This thing is screaming .18 cents!

Thanks! Captain Obvious....

I agree, sky's the limit!

IMO-I think LymPro is a vehicle to get MANF in a large amount of trials so maybe? JP, if your numbers are accurate I'm happy and if they are closer to mine, I'll just be happier!

JP, why $35-50? I think LymPro has more value than that, with AH, CE+TBI and include US+ROW......150m up front is not out of the question.

1.69 mil market cap! Let's hope not.

Just drilling down on Gerald's latest tweet;

@G_Commish: @Solantey Just finished, lots of great feedback. Only new thing is all sites for the Phase 2b identified and preparing to engage FDA/EMA.

LID partnership completed? Or grant?

Today Lympro tweet from Gerald responding to a question

@ScottGlibowski: @G_Commish are u still on tract to launch lympro in 4th quarter and no later? Also is there an issue with lympro partnership?


@G_Commish: @ScottGlibowski Nothing has changed - please no unfounded rumours. Everything remains on track as planned.

Cause he's bored of course.....lol

Tomorrow would be a good day to announce a partnership in Diego! IMO

Zoom, with a revenue guidence of 150 mil and a conservative 13X valuation the PPS should be 2.60, no R/S for an uplist!!!! Gerald commented about having other catalysts to maintain the PPS, which should be easy if Lympro revenue guidence is all that is needed for an uplist? Very interesting weeks and months ahead......

Valuations! Of revenues.........

They're in Diego to tell not show.....

Think about this , at 10 mil revenue per month for Lympro equates to 120 mil in revenue now most bio techs trade at a minimum of 13 times revenue, that is 2.06 per share. Add some grants or a JV and Boom no R/S! And 120 mil is conservative....